Researchers at the University of Cambridge have taken the first step towards developing a new form of treatment for type 1 diabetes which, if successful, could mean an end to the regular insulin injections endured by people affected by the disease, many of whom are children.
Artificial pancreas trial in young children with diabetes receives €4.6millon grant from European Commission05 Sep 2016
An international trial to test whether an artificial pancreas can help young children manage their type 1 diabetes will begin next year, thanks to a major grant awarded by the European Commission.
A chemical found in our breath could provide a flag to warn of dangerously-low blood sugar levels in patients with type 1 diabetes, according to new research from the University of Cambridge. The finding, published in the journal Diabetes Care, could explain why some dogs can be trained to spot the warning signs in patients.
Technology assisting people with type 1 diabetes edges closer to perfection.
Our immune systems vary with the seasons, according to a study led by the University of Cambridge that could help explain why certain conditions such as heart disease and rheumatoid arthritis are aggravated in winter whilst people tend to be healthier in the summer.
The success of a clinical trial hinges on its ability to recruit enough patients. Dr Frank Waldron-Lynch from the Cambridge Institute for Medical Research explains how the use of the internet to directly contact patients with type 1 diabetes greatly accelerated the recruitment leading to the early completion of his team’s study of a potential new treatment for type 1 diabetes.
Children with type 1 diabetes have been able to use pioneering artificial pancreas technology, developed at the University of Cambridge, for the first time overnight at home without the supervision of researchers.
Screening could enable early intervention